To reverse this immunosuppression, mRNA cancer vaccines are always used in combination with drugs to boost the immune response, such as immune checkpoint inhibitors (ipilimumab, anti-CTLA-4, pembrolizumab, and anti-PD-1) [194]. The gene discussed is PDCD1; the disease is cancer.